Unsere Gruppe organisiert über 3000 globale Konferenzreihen Jährliche Veranstaltungen in den USA, Europa und anderen Ländern. Asien mit Unterstützung von 1000 weiteren wissenschaftlichen Gesellschaften und veröffentlicht über 700 Open Access Zeitschriften, die über 50.000 bedeutende Persönlichkeiten und renommierte Wissenschaftler als Redaktionsmitglieder enthalten.

Open-Access-Zeitschriften gewinnen mehr Leser und Zitierungen
700 Zeitschriften und 15.000.000 Leser Jede Zeitschrift erhält mehr als 25.000 Leser

Abstrakt

A GFP Retinal Prion Proteins Intracellular Trafficking via Endocytic Intermediates

Tarunkanti Mondal

The prion protein (PrP) is a key molecule implicated in neurodegenerative disorders. Understanding its intracellular trafficking is essential for unraveling its physiological and pathological functions. This article focuses on the intracellular trafficking of a green fluorescent protein (GFP) tagged PrP in retinal cells, specifically exploring its transport via endocytic intermediates. Endocytic pathways, including clathrin-mediated endocytosis, caveolaemediated endocytosis, and macropinocytosis, play a crucial role in PrP internalization and trafficking. Endocytic intermediates, such as early endosomes, late endosomes, and lysosomes, are involved in sorting, recycling, and degradation of endocytosed proteins. Live-cell imaging and colocalization studies have provided insights into GFPPrP’s movement and localization within these organelles. Studies reveal rapid internalization of PrP via clathrinmediated endocytosis, with subsequent transport to early endosomes. A fraction of PrP is recycled, while the remainder progresses to late endosomes and lysosomes for degradation. Elucidating the intracellular trafficking of GFP-PrP and its association with endocytic intermediates enhances our understanding of PrP’s functions and implications in neurodegenerative diseases. Further investigations are needed to explore the molecular machinery involved and the impact of disease-associated mutations. This knowledge may contribute to potential therapeutic strategies for prion diseases.